10/15/2026
𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 is more than a common stomach infection, it’s an important clinical condition that deserves appropriate testing and follow-up.
The latest global cancer analysis identified 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 as a leading infectious contributor to cancer, linking the bacterium primarily to gastric cancers. These findings reinforce the importance of identifying active infection and confirming successful eradication after treatment.
A practical 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 care pathway includes:
• Test patients when clinically appropriate
• Treat confirmed infection according to current guidelines
• Confirm eradication after treatment
• Take appropriate next steps when infection persists
BreathID supports noninvasive assessment of active 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection and confirmation of eradication through a urea breath test.
is not a cancer-screening test. Its role is to help clinicians detect 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection and verify whether treatment has been successful.
Read the full article and learn more about incorporating 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 testing and test-of-cure into clinical workflows: https://hubs.li/Q04zX6F10